Previsioni di mercato della diagnostica per il cancro al cervello in Nord America fino al 2028 – Impatto del COVID-19 e analisi regionale per tipo diagnostico (test di imaging, puntura lombare, biopsia, test molecolari e altri); Tipo di cancro (neuroma acustico, astrocitoma, craniofaringiomi, ganglioneuromi, glioblastoma multiforme, meningiomi, ependimomi e altri); Utente finale (ospedali, cliniche specialistiche, centri chirurgici ambulatoriali e altri)

Introduzione al mercato

I tumori al cervello sono causati dalla crescita extracellulare delle cellule nel cervello che causano i tumori. Il tumore comprende tumori cerebrali primari e tumori cerebrali secondari. I tumori cerebrali primari si formano nel cervello e non si diffondono ad altre parti del corpo, mentre i tumori secondari, noti anche come metastasi, sono quei tumori che hanno avuto inizio in un\'altra parte del corpo. I tumori al cervello sono classificati in 40 tipi principali, ulteriormente classificati in due gruppi principali: benigni, ovvero a crescita lenta e con minore possibilità di diffusione, e maligni, ovvero cancerosi e con maggiore probabilità di diffusione.

< p>Pertanto, si prevede che l\'aumento della prevalenza del cancro al cervello creerà una domanda significativa per la diagnostica del cancro al cervello nei prossimi anni, che si prevede guiderà ulteriormente il mercato della diagnostica del cancro al cervello.

Il COVID-19 La pandemia ha sconvolto i sistemi sanitari, suscitando preoccupazioni circa il suo successivo impatto sulle patologie non-COVID. La diagnosi e il trattamento del cancro sono urgenti e possono essere significativamente influenzati da queste condizioni. Le attività di ciascuna disciplina oncologica sono state influenzate negativamente dalla pandemia di COVID-19. Inoltre, i tumori cerebrali maligni infantili sono caratterizzati da una rapida crescita e richiedono una diagnosi precoce e un trattamento appropriato. Pertanto, ritardare o modificare il trattamento può comprometterne l’efficacia e ridurre la sopravvivenza del paziente. Flores et al. hanno riferito che la diagnosi tardiva dei tumori cerebrali è correlata a una prognosi peggiore. Un prolungato intervallo sintomatico pre-diagnostico ha conseguenze negative e gravi, come la morte o gravi danni cerebrali a seguito dell\'aumento della pressione intracranica. A causa della paura e della pressione dell’infezione da SARS CoV2, i cambiamenti nel processo decisionale dei bambini con tumori al cervello possono avere un impatto negativo sul loro esito finale. I comitati multidisciplinari sui tumori non hanno mai svolto un ruolo cruciale durante l’attuale epidemia di COVID-19. Tutti i casi pediatrici con diagnosi di un nuovo tumore al cervello dovrebbero essere discussi nel comitato multidisciplinare dei tumori per determinare il miglior piano di trattamento per ciascun bambino.

Panoramica e dinamiche del mercato

Si prevede che il mercato della diagnostica del cancro al cervello in Nord America crescerà da 301,5 milioni di dollari nel 2021 a 911,0 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 17,1% dal 2021 al 2028. I ricercatori hanno sottolineato che la capacità della tecnologia dell\'intelligenza artificiale e dei patologi di verificarsi a vicenda evidenzia la necessità che i patologi cooperino con la tecnologia dell\'intelligenza artificiale per interpretare casi difficili e garantire la massima accuratezza diagnostica possibile. Oggi, diversi importanti centri oncologici negli Stati Uniti utilizzano gli imager SRH. Sia l’SRH che l’imaging AI sono tecnologie emergenti, quindi integrarle nell’assistenza sanitaria sarà impegnativo. La tecnologia AI consente ai chirurghi di identificare aree contenenti tumori o tessuti sani in modo rapido e preciso. Pertanto, l\'intelligenza artificiale SRH viene sempre più utilizzata per migliorare la diagnosi del tumore al cervello durante l\'intervento chirurgico.

Segmenti chiave del mercato

In termini di tipo diagnostico, il segmento dei test di imaging ha rappresentato la quota maggiore del mercato nordamericano della diagnostica del cancro al cervello nel 2020. In termini di tipo di cancro, il segmento del glioblastoma multiforme ha rappresentato la quota maggiore quota del mercato nordamericano della diagnostica per il cancro al cervello nel 2020. In termini di utenti finali, il segmento ospedaliero ha rappresentato la quota maggiore del mercato nordamericano della diagnostica per il cancro al cervello nel 2020.

Principali fonti e aziende elencate

Alcune principali fonti primarie e secondarie Per la preparazione di questo rapporto sul mercato della diagnostica del cancro al cervello in Nord America sono stati citati i siti Web aziendali, le relazioni annuali, i rapporti finanziari, i documenti del governo nazionale e i database statistici, tra gli altri. Le principali aziende elencate nel rapporto sono Thermo Fisher Scientific Inc., Siemens Healthineers A, GE Healthcare, MDxHealth, NantOmics, Biocept, Inc., Koninklijke Philips NV, Canon Medical Systems, Hitachi, Ltd. e Neusoft Medical Systems.

Rapporto sui motivi per acquistare

Comprendere il panorama del mercato della diagnostica del cancro al cervello in Nord America e identificare i segmenti di mercato più probabilmente garantirà un forte ritorno
Mantieni un vantaggio comprendendo il panorama competitivo in continua evoluzione per il mercato della diagnostica del cancro al cervello in Nord America
Pianifica in modo efficiente fusioni e acquisizioni e accordi di partnership nel Nord Mercato americano della diagnostica del cancro al cervello identificando i segmenti di mercato con le vendite probabili più promettenti
Aiuta a prendere decisioni aziendali consapevoli attraverso un\'analisi percettiva e completa delle prestazioni di mercato di vari segmenti del mercato della diagnostica del cancro al cervello in Nord America
Ottieni previsioni sui ricavi di mercato per vari segmenti dal 2021 al 2028 nella regione del Nord America.

Segmentazione del mercato della diagnostica per il cancro al cervello in Nord America

Per tipo diagnostico

< ul>

Test di imaging

Biopsia

Test molecolari

Puntura lombare

Altro

Per tipo di cancro

Glioblastoma multiforme
Astrocitomi
Ependimomi
Altro

Da utente finale

Ospedali
Cliniche specializzate
Centri chirurgici ambulatoriali
Altro

Per paese

Nord America
- Stati Uniti
- Canada
- Messico

Aziende citate

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Brain Cancer Diagnostics Market – By Diagnostic Type

1.3.2 Brain Cancer Diagnostics Market – By Cancer Type

1.3.3 Brain Cancer Diagnostics Market – By End User

1.3.4 North America Brain Cancer Diagnostics Market – By Country

2. North America Brain Cancer Diagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Brain Cancer Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Brain Cancer Diagnostics Market- North America PEST Analysis

4.3 Expert Opinion

5. North America Brain Cancer Diagnostics Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Brain Cancer

5.1.2 Rise in Number of Cigarette Smokers

5.2 Market Restraints

5.2.1 High Cost of Diagnosis

5.3 Future Trends

5.3.1 Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery

5.4 Impact Analysis

6. Brain Cancer Diagnostics Market – North America Analysis

6.1 North America Brain Cancer Diagnostics Market Revenue Forecasts and Analysis

7. North America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type

7.1 Overview

7.2 Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

7.3 Imaging Tests

7.3.1 Overview

7.3.2 Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 MRI

7.3.3.1 Overview

7.3.3.2 MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 CT Scan

7.3.4.1 Overview

7.3.4.2 CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5 Positron emission tomography (PET)

7.3.5.1 Overview

7.3.5.2 Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Lumbar Puncture

7.4.1 Overview

7.4.2 Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Biopsy

7.5.1 Overview

7.5.2 Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Molecular Testing

7.6.1 Overview

7.6.2 Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8. North America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type

8.1 Overview

8.2 Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

8.3 Astrocytomas

8.3.1 Overview

8.3.2 Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Glioblastoma Multiforme

8.4.1 Overview

8.4.2 Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Ependymomas

8.5.1 Overview

8.5.2 Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Brain Cancer Diagnostics Market Analysis – By End user

9.1 Overview

9.2 Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Specialty Clinics

9.4.1 Overview

9.4.2 Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Ambulatory Surgical Centers

9.5.1 Overview

9.5.2 Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1 North America: Brain Cancer Diagnostics Market

10.1.1 Overview

10.1.2 North America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.3 US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.1 US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.2 US Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

10.1.3.2.1 US Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.3.3 US Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.3.4 US Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.4 Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.4.1 Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.4.2 Canada Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

10.1.4.2.1 Canada Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.4.3 Canada Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.4.4 Canada Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.5 Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.1 Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.2 Mexico Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

10.1.5.2.1 Mexico Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.5.3 Mexico Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.5.4 Mexico Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11. Impact Of COVID-19 Pandemic on North America Brain Cancer Diagnostics Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.1 Organic Developments

12.1.1 Overview

12.2 Inorganic Developments

12.2.1 Overview

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Siemens Healthineers AG

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GE Healthcare

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 MDxHealth

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 NantOmics

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Biocept, Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Koninklijke Philips N.V.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Canon Medical Systems

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Hitachi, Ltd.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Neusoft Medical Systems

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. US Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

Table 2. US Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 3. US Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 4. US Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5. Canada Brain Cancer Diagnostics Market, by Diagnostic Type - Revenue and Forecast to 2028 (USD Million)

Table 6. Canada Brain Cancer Diagnostics Market, by Imaging Test - Revenue and Forecast to 2028 (USD Million)

Table 7. Canada Brain Cancer Diagnostics Market, by Cancer Type - Revenue and Forecast to 2028 (USD Million)

Table 8. Canada Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. Mexico Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

Table 10. Mexico Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 11. Mexico Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 12. Mexico Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. Organic Developments in the Brain Cancer Diagnostics Market

Table 14. Inorganic Developments in the Brain Cancer Diagnostics Market

Table 15. Glossary of Terms, Brain Cancer Diagnostics Market

LIST OF FIGURES

Figure 1. Brain Cancer Diagnostics Market Segmentation

Figure 2. North America Brain Cancer Diagnostics Market Overview

Figure 3. Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market

Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. Brain Cancer Diagnostics Market - North America PEST Analysis

Figure 6. Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints

Figure 7. North America Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8. Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

Figure 9. Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

Figure 18. Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

Figure 23. Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. North America: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 28. North America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 29. US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Impact of COVID-19 Pandemic in North American Country Markets

Figure 33. Growth Strategies Done by the Companies in the Market, (%)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America brain cancer diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample